FDA
- Status: approved
Atorvastatin-ranitidine (Atorvastatin-ranitidine) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec is the originator. The local marketing authorisation holder may differ — check the official source linked above.